Antibody library technologies are the methods which help to study the protein-peptide, protein-protein, protein-DNA interactions. These technologies uses bacteriophages, mRNA, yeast, and bacteria for antibody screening. Amplification and screening of antibodies can be done by using these technologies. Among all the technologies phase display proven to be most popular and robust one for improved method of antibody selection from libraries. Phase display technology has its own merits owing to its highly specific antibody production capability. Use of monoclonal antibodies (mAbs) in several human diseases as drug of choice and diagnosis of diseases by using mAbs is expected to drive the growth of antibody library market.
Antibody library technology Market: Drivers and Restraints
Global antibody library technology market is continue to witness positive growth owing to higher demand for biopharmaceutical formulations for treatment and diagnosis. Increased prevalence of autoimmune disease and rising incidence of cancer will boost this market positively. Advent of technologies like Human combinatorial antibody library (HuCAL) and n-CoDeR will help to bolster growth of antibody library technology market. Rising support for these technologies from medical fraternity owing to increased demand for novel therapeutic options is expected to fuel the market growth over forecasted period. However increased developmental cost and decreased R & D efforts across underdeveloped countries would hamper the growth of this market.
Download Sample of this report @ http://www.persistencemarketresearch.com/samples/11155
Antibody library technology Market: Segmentation
Global antibody library technology market has been segmented on the basis of type, application, end user and region.
Based on the type, the global antibody library technology market is segmented into the following:
- Phase Display
- Ribosome Display
- Yeast Display
- Bacteria Display
Based on the application, the global antibody library technology market is segmented into the following:
- Drug Discovery
- Disease Diagnosis
Based on the end user, the global antibody library technology market is segmented into the following:
- Bio-Pharmaceutical companies
- Research centers
Antibody library technology Market: Overview
Global antibody library technology market is witnessing significant changes owing to the active intervention by the companies in terms of agreements between the companies and academia. The market is expected witness a promising change in its market dynamics over the forecast period owing to advent of new technologies. By application, drug discovery application segment is expected to represent positive growth owing to growing prevalence of autoimmune disease and cancer.
Antibody library technology Market: Region-wise Outlook
Geographically, antibody library technology market is segmented into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East and Africa. North America and Europe will remain key markets for antibody library technology market due to increased attention for the diagnosis of disease among health care professionals. Asia Pacific is anticipated to register positive growth owing to government initiatives, increased presence of key players in the region.
For more info (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/toc/11155
Antibody library technology Market: Key Players
Some of the key players in the global antibody library technology market are GenScript, MedImmune, MorphoSys AG, BioInvent International AB, Source BioScience, Bio-Rad Laboratories, Abcheck to name few.